Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TEPLEXER-CR50
- Development stage
- Unknown
- Lead developer
- Zaiva Lifesciences
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
TEPLEXER-CR50 is a branded generic formulation of tapentadol, an opioid analgesic, produced by Zaiva Lifesciences. It is an extended-release tablet containing 50 mg of the active ingredient. Tapentadol utilizes a dual mechanism of action, acting as an agonist at the mu-opioid receptor and as a norepinephrine reuptake inhibitor, which together modulate pain transmission in the central nervous system. This medication is indicated for the management of moderate to severe acute pain, including conditions such as musculoskeletal pain, dental pain, and primary dysmenorrhea. Due to its opioid nature, it carries risks of respiratory depression and physical dependence.
- Brand names
- TEPLEXER-CR50TEPLEXER-CR-50TEPLEXER-CR 50Teplex ER 50
- Other names
- Tapentadol extended-release
02
Targets
NET (Norepinephrine Transporter)MOR (Mu opioid receptor)
Beyond the preview
Go deeper on TEPLEXER-CR50.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TEPLEXER-CR50.